BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 30744964)

  • 1. Vaccination of patients with haematological malignancies who did not have transplantations: guidelines from the 2017 European Conference on Infections in Leukaemia (ECIL 7).
    Mikulska M; Cesaro S; de Lavallade H; Di Blasi R; Einarsdottir S; Gallo G; Rieger C; Engelhard D; Lehrnbecher T; Ljungman P; Cordonnier C;
    Lancet Infect Dis; 2019 Jun; 19(6):e188-e199. PubMed ID: 30744964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7).
    Cordonnier C; Einarsdottir S; Cesaro S; Di Blasi R; Mikulska M; Rieger C; de Lavallade H; Gallo G; Lehrnbecher T; Engelhard D; Ljungman P;
    Lancet Infect Dis; 2019 Jun; 19(6):e200-e212. PubMed ID: 30744963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of vaccines to safeguard patients with haematological malignancies.
    Sekkides O
    Lancet Infect Dis; 2019 Jun; 19(6):572. PubMed ID: 30744960
    [No Abstract]   [Full Text] [Related]  

  • 4. Current issues in vaccines for adult patients with hematologic malignancies.
    Issa NC; Baden LR
    J Natl Compr Canc Netw; 2012 Nov; 10(11):1447-54; quiz 1454. PubMed ID: 23138170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterial infections in adults with haematological malignancies and haematopoietic stem cell transplants: guidelines from the 8th European Conference on Infections in Leukaemia.
    Bergeron A; Mikulska M; De Greef J; Bondeelle L; Franquet T; Herrmann JL; Lange C; Spriet I; Akova M; Donnelly JP; Maertens J; Maschmeyer G; Rovira M; Goletti D; de la Camara R;
    Lancet Infect Dis; 2022 Dec; 22(12):e359-e369. PubMed ID: 35636446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5).
    Mallet V; van Bömmel F; Doerig C; Pischke S; Hermine O; Locasciulli A; Cordonnier C; Berg T; Moradpour D; Wedemeyer H; Ljungman P;
    Lancet Infect Dis; 2016 May; 16(5):606-617. PubMed ID: 27599653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antibody response of haematological malignancies to COVID-19 infection and vaccination.
    Seebacher NA
    Br J Cancer; 2022 Mar; 126(5):691-692. PubMed ID: 35017657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination in patients with primary immune deficiency, secondary immune deficiency and autoimmunity with immune regulatory abnormalities.
    Eibl MM; Wolf HM
    Immunotherapy; 2015; 7(12):1273-92. PubMed ID: 26289364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in vaccinating immunocompromised children.
    Miller K; Leake K; Sharma T
    Curr Opin Pediatr; 2020 Feb; 32(1):145-150. PubMed ID: 31790029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients.
    Cordonnier C; Cesaro S; Maschmeyer G; Einsele H; Donnelly JP; Alanio A; Hauser PM; Lagrou K; Melchers WJ; Helweg-Larsen J; Matos O; Bretagne S; Maertens J;
    J Antimicrob Chemother; 2016 Sep; 71(9):2379-85. PubMed ID: 27550990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in Infectious Diseases for Haematologists.
    von Lilienfeld-Toal M; Maschmeyer G
    Oncol Res Treat; 2018; 41(6):406-410. PubMed ID: 29734194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
    Menzies R; Turnour C; Chiu C; McIntyre P
    Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia, 1999 to 2002.
    Menzies R; McIntyre P; Beard F
    Commun Dis Intell Q Rep; 2004; 28(2):127-59. PubMed ID: 15460950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients.
    Maertens J; Cesaro S; Maschmeyer G; Einsele H; Donnelly JP; Alanio A; Hauser PM; Lagrou K; Melchers WJ; Helweg-Larsen J; Matos O; Bretagne S; Cordonnier C;
    J Antimicrob Chemother; 2016 Sep; 71(9):2397-404. PubMed ID: 27550992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in vaccinations in European Union.
    Esposito S; Principi N
    Hum Vaccin; 2008; 4(4):313-5. PubMed ID: 18398297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination of the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient.
    Kamboj M; Shah MK
    Infect Dis Clin North Am; 2019 Jun; 33(2):593-609. PubMed ID: 31005140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia.
    Maertens JA; Girmenia C; Brüggemann RJ; Duarte RF; Kibbler CC; Ljungman P; Racil Z; Ribaud P; Slavin MA; Cornely OA; Peter Donnelly J; Cordonnier C; ;
    J Antimicrob Chemother; 2018 Dec; 73(12):3221-3230. PubMed ID: 30085172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors-Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO).
    Rieger CT; Liss B; Mellinghoff S; Buchheidt D; Cornely OA; Egerer G; Heinz WJ; Hentrich M; Maschmeyer G; Mayer K; Sandherr M; Silling G; Ullmann A; Vehreschild MJGT; von Lilienfeld-Toal M; Wolf HH; Lehners N;
    Ann Oncol; 2018 Jun; 29(6):1354-1365. PubMed ID: 29688266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine-preventable infection morbidity of patients with chronic kidney disease and cocoon vaccination strategies.
    Bitsori M; Galanakis E
    Expert Rev Vaccines; 2015; 14(10):1385-95. PubMed ID: 26289972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mandatory and recommended vaccination in the EU, Iceland and Norway: results of the VENICE 2010 survey on the ways of implementing national vaccination programmes.
    Haverkate M; D'Ancona F; Giambi C; Johansen K; Lopalco PL; Cozza V; Appelgren E;
    Euro Surveill; 2012 May; 17(22):. PubMed ID: 22687916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.